The Effect of Stellate Ganglion Block on Intracranial Pressure Predicted by Ultrasonographic Assessment of Optic Nerve Sheath Diameter

Sponsor
Yonsei University (Other)
Overall Status
Completed
CT.gov ID
NCT01840995
Collaborator
(none)
35
1
8
4.4

Study Details

Study Description

Brief Summary

The stellate ganglion block increase cerebral blood flow, as the consequence of that, it has the potential to cause an increase of intracranial pressure (ICP). Previous studies have proposed that ultrasonographic measurements of the optic nerve sheath diameter (ONSD) correlate with signs of increased ICP. Therefore, this study is aim to confirm the increased ICP by ultrasonographic measurement of ONSD after the stellate ganglion block.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ultrasonographic measurement of optic nerve sheath diameter

Study Design

Study Type:
Observational
Actual Enrollment :
35 participants
Time Perspective:
Prospective
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Dec 1, 2013
Actual Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
stellate ganglion block

Patients receiving stellate ganglion block at our pain management clinic

Procedure: ultrasonographic measurement of optic nerve sheath diameter
A thick layer of gel is applied on the upper closed eyelid. The linear 13- to 6-MHz ultrasound probe is then placed in the gel, without exerting pressure on the eye. Two measurements are taken for each optic nerve: one in the transverse plane, with the probe being horizontal, and one in the sagittal plane, with the probe being vertical. The final ONSD is the mean of these measurements.

Outcome Measures

Primary Outcome Measures

  1. ultrasonographic measurement of optic nerve sheath diameter [15 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients (20-70 years of age)

  • who were scheduled to receive stellate ganglion block at our pain management clinic

Exclusion Criteria:
  • Patients with previous history of neurologic disease, carotid disease, transient ischemic attack, ocular disease and ocular surgery

  • Patients with coagulation disorder

  • Patients with severe obesity

  • Patients with severe cardiovascular or pulmonary disease

  • Patients with cognitive deficits or psychiatric illness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Severance Hospital Seoul Korea, Republic of 120-752

Sponsors and Collaborators

  • Yonsei University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT01840995
Other Study ID Numbers:
  • 4-2013-0078
First Posted:
Apr 26, 2013
Last Update Posted:
Jan 28, 2015
Last Verified:
Jan 1, 2015
Keywords provided by Yonsei University

Study Results

No Results Posted as of Jan 28, 2015